IPP Bureau
Asahi Kasei Life Science begins operation
By IPP Bureau - April 03, 2025
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Amcor's Bloom Biorenewables secures $14 million Series A Funding
By IPP Bureau - April 03, 2025
Bloom has pioneered a technology to transform plant waste into valuable chemical products
Peter Bains appointed MD & CEO of Syngene International
By IPP Bureau - April 02, 2025
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Glenmark Pharmaceuticals USA launches Vancomycin Hydrochloride for Injection
By IPP Bureau - April 02, 2025
According to IQVIA sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) market achieved annual sales of approximately $39.3 mn
Emcutix and WiQo sign licensing partnership for derma-cosmetic treatments in India
By IPP Bureau - April 02, 2025
PRX-PLUS has a unique product feature with its deep-impacting formula
SK Capital invests in Spectrum Vascular
By IPP Bureau - April 02, 2025
Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024
Coveris launches circular solution for stretch sleeves with ReCover
By IPP Bureau - April 02, 2025
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
Morrisons introduces sensory support boxes in store for autistic and neurodiverse customers
By IPP Bureau - April 02, 2025
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
Shin-Etsu Chemical to invest in pharmaceutical cellulose business
By IPP Bureau - April 01, 2025
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
HRV Global Life Sciences delivers Indian anti-diabetic drugs to Argentina
By IPP Bureau - April 01, 2025
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system
Morepen secures Loratadine approval for export to China
By IPP Bureau - April 01, 2025
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
GE HealthCare launches new advanced CT system
By IPP Bureau - April 01, 2025
GE HealthCare’s Revolution Vibe CT enables more facilities to elevate patient care by offering advanced cardiac imaging technology
Briefs: AstraZeneca Pharma India, Pharmaids and Dr. Agarwal's Health Care
By IPP Bureau - April 01, 2025
AstraZeneca Pharma India discontinues manufacturing of Imdur
NCLT approves amalgamation of Cohance Lifesciences into and with Suven Pharmaceuticals
By IPP Bureau - April 01, 2025
The amalgamation is expected to create a future-ready, diversified CDMO platform with a technology-led focus across three high-growth verticals-Antibody Drug Conjugates
Akums launches Ripasudil + Timolol combination for glaucoma treatment
By IPP Bureau - April 01, 2025
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
